Biodesix Common Stock Net 2020-2024 | BDSX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biodesix common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biodesix common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$93.6B
Cencora (COR)	$48.4B
DiDi Global (DIDIY)	$22.9B
Natera (NTRA)	$22.4B
ICON (ICLR)	$17.6B
Viatris (VTRS)	$15.8B
Avantor (AVTR)	$13.9B
Revvity (RVTY)	$13.5B
CochLear (CHEOY)	$12.6B
BioMerieux (BMXMF)	$12.1B
Solventum (SOLV)	$12B
Medpace Holdings (MEDP)	$10.6B
Charles River Laboratories (CRL)	$9.9B
HealthEquity (HQY)	$9.1B
Doximity (DOCS)	$9B
Sonic Healthcare (SKHHY)	$8.8B
Bausch + Lomb (BLCO)	$7B
Life Times (LTH)	$5B
Organon (OGN)	$3.8B
Sotera Health (SHC)	$3.5B
BrightSpring Health Services (BTSG)	$3.3B
Surgery Partners (SGRY)	$3B
Concentras Parent (CON)	$2.7B
PACS (PACS)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
Ardent Health Partners (ARDT)	$2.3B
Premier (PINC)	$2.2B
Ryman Healthcare (RYHTY)	$2B
GeneDx Holdings (WGS)	$2B
Teladoc Health (TDOC)	$1.8B